+44 (0) 20 7556 4465 sakram@cooley.com
Download full bio
Decibel on its $160 Million Agreement to Sell to Medallia Inc.
Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million
Emerging Companies
Venture Capital
Super Group to Combine With SPAC Sports Entertainment Acquisition Corp. April 25, 2021
Orchard Therapeutics Closes $150 Million Series C September 27, 2018
+44 (0) 20 7556 4465 office sakram@cooley.com
22 BishopsgateLondon, UK EC2N 4BQ